UPDATE 1-Zafgen to scrap lead obesity drug, cut jobs
 

UPDATE 1-Zafgen to scrap lead obesity drug, cut jobs
July 19 (Reuters) - Zafgen Inc said it wassuspending the development of its lead obesity drug, beloranib,more than six months after the U.S. Food and Drug Administrationasked the company to halt...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...-Q:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...-Q:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/tqM7pWwMsOI